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Abstract
Objectives To evaluate the spectrum of diagnostic find-
ings in hysterosalpingography (HSG) examinations per-
formed at our institution between 2006–2010 and their
prognostic significance for treatment decisions and fer-
tility outcomes.
Methods Patients were filtered from our PACS. Patho-
logical HSG studies were re-evaluated. Indications for
referral, technical success and diagnostic findings were
analysed. Pathological findings were correlated with
further diagnostic workups, treatments and fertility
outcomes.
Results Of 411 HSG examinations, 226 (55 %) were
normal, 94 (23 %) showed minor abnormalities and 5
(1.2 %) were not diagnostic. Eighty-six (21 %) exami-
nations were pathological. Twenty-nine patients under-
went subsequent laparoscopy, during which proximal
tubal occlusion diagnosed at HSG was ruled out in 9/
23 cases. Follow-up information was unavailable for 20
patients. Nineteen of 66 patients with follow-ups after
pathological HSG had at least one subsequent successful
pregnancy. Forty-one patients had no further treatment
and no pregnancies.
Conclusions The detection rate for pathologies at HSG
was low (21 %). There was a high false-positive rate
(39 %) for proximal tubal occlusion, most likely because
of spasms, demonstrating the importance of delayed im-
aging after injection of antiperistaltic agents. HSG
remains a valuable diagnostic tool. Our results, however,
indicate that this technique should be more selectively
indicated.
Main Messages
• Good acceptance of HSG by the patients. No complica-
tions with antibiotic prophylaxis.
• Low detection rate (21 % pathological exams) for pathol-
ogies in our study.
• High false-positive rate for proximal tubal occlusion.
• This demonstrates the importance of waiting longer after
injection of buscopan.
• High pregnancy rate in pathological cases: Indication too
broad or even a therapeutic effect of HSG?
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Introduction
Approximately 15 % of couples are affected by infertility,
which is defined as the inability to conceive after 12 months
of regular unprotected sexual intercourse [1]. Common
causes of infertility include male factor (45 %), ovulation
disorders (37 %) and tubal damage (18 %) [2]. A combina-
tion of several factors is found in approximately 20 % of all
couples. The etiology of tubal damage can be intrinsic
(ascending salpingitis, including salpingitis isthmica
nodosa) or extrinsic (peritonitis, endometriosis and pelvic
surgery). The most common causes of pelvic inflammatory
disease (PID) are Chlamydia trachomatis, Neisseria gonor-
rhoeae and multibacterial infections [3]. Studies have dem-
onstrated that the severity of tubal damage found in infertile
women is directly related to their serum chlamydia antibody
IgG titer (CAT) [4].
Uterine cavity abnormalities can be a contributing cause
of subfertility in 10 % of women. Abnormal uterine findings
are reported in as many as 50 % of women with recurrent
implantation failure [5]. These findings include endometrial
polyps or fibroids, which are observed as filling defects or
uterine wall irregularities using hysterosalpingography
(HSG). HSG can also demonstrate intrauterine adhesions
and congenital abnormalities [1].
Imaging plays a key role in the diagnostic evaluation of
female infertility [6]. Transvaginal ultrasound (TVUS) is a
standard, first-choice procedure. Abnormal findings can be
further evaluated with saline or contrast hysterosalpingo
sonography [1]. Hysterosalpingo contrast sonography
(HyCoSy) has been found to be highly sensitive, specific
and accurate in identifying uterine abnormalities, e.g., pol-
yps. However, it is of limited value for the assessment of
tubal abnormalities. Magnetic resonance imaging (MRI) can
be used to evaluate congenital Müllerian duct anomalies and
to diagnose adenomyosis, leiomyoma and endometriosis;
however, its role in tubal assessment is presently limited
[7, 8].
The primary role of HSG is to evaluate the morphology
and the patency of the fallopian tubes. The fallopian tubes
should appear as thin, smooth lines that widen in the am-
pullary portion. Tubal abnormalities observed with HSG can
be congenital, or due to spasm, occlusion or infection. Tubal
occlusion manifests as an abrupt cutoff of contrast material
with non-opacification of the distal fallopian tube, and can
be unilateral or bilateral. Peritubal adhesions prevent con-
trast material from spilling into the abdominal cavity and
distributing freely [8, 9].
HSG can also be helpful in evaluating uterine cavity
abnormalities. It is considered to have a high sensitivity
(60–98 %) but low specificity (15–80 %) in detecting uter-
ine abnormalities, and hysteroscopy remains the method of
choice for the final assessment. The differential diagnosis of
intrauterine filling defects by HSG includes polyps, endo-
metrial hyperplasia, submucosal fibroids, intrauterine adhe-
sions and septa. These findings necessitate further
investigation with hysteroscopy to confirm and possibly
treat the pathology [1]. In the literature, the results of HSG
studies have been shown to be important for selecting
patients for diagnostic laparoscopy with chromopertubation
[9, 10].
In 2008, guidelines published by the European Society of
Human Reproduction and Embryology (ESHRE) recom-
mended that a semen analysis and an ovulation assessment
should be performed before a tubal patency test. Women
with a high probability of pathological conditions should be
offered a first line laparoscopy. This approach has the ad-
vantage that any tubal or pelvic pathology can be investi-
gated and treated at the same time. The ovaries can be
assessed by TVUS according to the ESHRE guidelines
[11, 12]. Following these guidelines, we advise women to
undergo a first line laparoscopy combined with hystero-
scopy if they have a history of previous pelvic surgery,
PID, elevated CAT, or severe dysmenorrhea or dyspareunia.
The purposes of this study were to evaluate all patholo-
gies that were diagnosed by HSG in the workup of female
infertility at our institution between 2006 and 2010, to
describe the spectrum of diagnostic findings, and to corre-
late the diagnostic findings with clinical findings and
outcomes.
Patients and methods
Patients were identified by searching the radiology informa-
tion system (RIS) for all HSG examinations from September
2006 (introduction of our Picture Archiving and Communi-
cation System; PACS) to April 2010. A total of 411 HSG
examinations were identified and included in the study. The
ages of the patients ranged between 22 and 42 years, and the
mean age was 32.6 years.
For most patients, diagnostics and treatment were per-
formed in our department. Some patients were sent to our
department only for tubal assessment by their gynaecologists
or family doctors. In selected cases, follow-up information
concerning pregnancy or pathological findings was therefore
not available.
Our department of gynecology specialises in the diagnosis
of infertility and its treatment, including in vitro fertilisation
(IVF). The Department of Gynecology as well as the Institute
of Radiology are certified by DIN EN ISO 9001:2000.
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Approximately 450 intrauterine insemination (IUI) cycles and
450 fresh/frozen IVF/intracytoplasmatic sperm injection
(ICSI) cycles were performed.
HSG examination
Patients were scheduled between the 7th and 12th day of
their menstrual cycle to ensure a thin endometrium, which
makes interpretation of the images easier. A preovulatory
exam was performed to exclude an early pregnancy. Contra-
indications, beside pregnancy, included pelvic inflammatory
disease and severe allergy against iodine contrast agents.
The patients were empty-stomached for the procedure.
At our institution, HSG is performed under sedation with
propofol. This sedation is performed by an anesthiologist,
and the patient is preinformed of the theoretical risks, e.g.,
aspiration or allergic reaction. Therefore, the HSG proce-
dure is very well tolerated by the patients. An antibiotic is
administered if tubal occlusion has been diagnosed to pre-
vent pelvic infection. Furthermore, antibiotic prophylaxis is
also given to patients at risk for infection, e.g., those with
cardiac valvular disease.
The cervical os is cannulated by the gynaecologists with
a Cohen catheter (manufactured by Storz, Germany). When
the catheter is in place, water-soluble iodinated contrast
medium (Telebrix® Hystero Guerbet AG, France) is applied
under fluoroscopic control. The contrast medium demon-
strates the morphology and contours of the uterine cavity.
Further injection of contrast medium will outline the cornua,
isthmic and ampullary portions of the tubes, and will show
the degree of spillage into the abdominal cavity and the
patency of the tubes. If one or both tubes show no contrast
spillage into the abdominal cavity, the possibility of tubal
spasm must be excluded by intravenous administration of
scopalamin (Buscopan® 20 mg) and further contrast admin-
istration. As soon as the patient's heart rate—as sign of the
effect of Buscopan®—shows an increase on the monitoring
system, additional fluoroscopic imaging is performed.
At our institution, four radiographs are taken after
contrast administration in each patient, including images
of the early and complete filling phases of the uterine
cavity, outlining of the fallopian tubes and the contrast
spillage into the abdominal cavity. Additional images
can be recorded in selected cases, e.g., following ad-
ministration of antiperistaltic agents, but are rarely nec-
essary. For radiation protection, our medical staff is
continuously trained to reduce the radiation exposure
to a minimum. The radiation dose was calculated for
random samples. The values varied between 1.5 and
3 mSv (in comparison, the mean radiation dose of a
chest X-ray is 0.01 mSv). The dose was dependent on
the fluoroscopy duration and patient-specific factors.
Higher doses in some individual cases can occur.
Following the examination, the radiologist and gynae-
cologist evaluated the images together, and a diagnosis
was made in consensus. The radiological report and
images were archived in our PACS.
Data analysis
All reports on the 411 selected patients were reviewed for
this study by two radiologists (AS, RK) together with a
gynaecologist (NF). In all cases in which pathology was
described in the report, the images were re-evaluated. The
size and morphology of the uterine cavity were assessed.
This included searching for uterine filling defects, contour
abnormalities of the cavity as well as abnormal positioning.
The images were reviewed to determine if the fallopian
tubes were existent and patent.
Tubal pathologies were categorised by occlusion
(one- or two-sided, proximal and distal, postsurgical,
spasm), tubal irregularity (postinfectious) and peritubal
adhesions (e.g., PID). The degree and distribution of
contrast spillage were recorded. Abnormalities of the
uterine cavity were categorised into Müllerian duct
anomalies (e.g., uterus bicornis) and filling defects (my-
oma, scars/adhesions). The size and position of the
cavity were assessed. Pathologies were categorised using




























Fig. 1 Scheme used for the characterisation of HSG findings, adapted
from [6]
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Correlation of clinical findings with fertility outcomes
Sonographic, hysteroscopic and laparoscopic findings, and
further information (i.e., history of previous surgery or
infection) were retrieved from the gynaecology case histo-
ries for all patients with a pathological HSG. Indications for
referral, technical success and diagnostic findings were ana-
lysed. Pathological findings were correlated with further
diagnostic workup, fertility treatment and fertility outcome
(i.e., pregnancy).
Results
No immediate, i.e., allergy to the iodinated contrast agent or
propfol, or delayed, i.e., pelvic infections, complications
were observed during or following any of the 411 examina-
tions. Of the 411 HSG examinations, 226 (55 %) were
normal. In 15 of the examinations that were assessed as
normal, administration of Buscopan® was required to dif-
ferentiate spastic tubal occlusion from true tubal occlusion.
There were minor abnormalities observed in 94 examina-
tions (23 %). Five examinations (1.2 %) were not diagnostic
(early termination of the exam due to venous filling of the
uterine plexus).
In 86 (21 %) of the examinations, at least one pathology
was described that was probably or possibly relevant to
female infertility (Table 1). The detailed analysis of our
study was based on this subpopulation. There was a statis-
tically significant age difference between patients with nor-
mal (mean 31.8 years) and pathological (mean 34.1 years)
HSG examinations (P-value00.0001).
Of these 86 patients, 30 solely uterine pathologies were
identified. The most common uterine pathologies were fill-
ing defects (n015, Figs. 2 and 3) and Müllerian duct anoma-
lies (n011), including arcuate uterus, hypoplastic uterus,
uterus septus (Fig. 4) and uterus bicornis bicollis (Fig. 5a
and b). A few patients (n04) had minor abnormalities of the
uterine cavity that were described as likely originating from
mucosal irregularities (Table 1).
In 47 of the 86 examinations, tubal pathologies were
present, and one-sided tubal occlusion (n017) was the most
common finding. Five of these patients had a history of
salpingectomy. Further findings included bilateral tubal oc-
clusion, sactosalpinx (Fig. 6), postinfectious tube abnormal-
ities, including salpingitis isthmica nodosa (Fig. 7), and
peritubal adhesions. One patient had several pathological
findings. As shown in Table 1, 9 of the 86 HSG examina-
tions demonstrated combined uterine and tubal pathologies.
Further diagnostic imaging workups were performed in 25
patients (24 TVUS and 1 MRI of the pelvis; Fig. 5b).
Additionally, 29 laparoscopies (LSC) and 19 hysteros-
copies (HSC) were performed on 34 different patients.
Three additional pathologies of the uterine cavity (2 small
polyps and a single myoma) were identified that were not
visible in the HSG. Nine of the 23 one- or two-sided prox-
imal tubal occlusions diagnosed by HSG were normal at
laparoscopy, resulting in a false-positive value of 39 %. On
the contrary, HSG showed a high negative predictive value
(100 %): No additional tube pathologies were identified at
LSC if the tube morphology was normal at HSG. In the nine
patients mentioned above, LSC (n05) and HSC (n04) were
combined with an intervention (tuboneostomy, myoma re-
section or one-sided salpingectomy).
A very common procedure following a pathological HSG
was insemination because of male subfertility. This proce-
dure was performed as long as one of the fallopian tubes
was described as normal and the uterine cavity had no major
pathology.
In total, there were 27 pregnancies in 25 of the 86
patients (including 20 patients lost to follow-up, see
below) with a pathological condition at HSG. These
pregnancies resulted in the birth of 19 healthy children
and 8 miscarriages.
Seventeen of the 25 patients only bore a healthy child.
These 17 patients had the following HSG results: one-sided
tubal occlusion (n06), adhesions (n04, one of these with
uterus arcuatus), filling defects (n05), tubal irregularities,
possibly postinfectious (n01) and sactosalpinx (n01).
Two of the 25 women had miscarriages followed by
successful pregnancies. Both of these patients showed fill-
ing defects, and one patient had additional tube irregulari-
ties, which were possibly postinfectious.
Six of the 25 patients had pregnancies that resulted in
spontanteous abortions. In these six patients, the HSG showed
one-sided tubary occlusion (n02), two-sided tubal occlusion
(n02), adhesions (n01) and an arcuate uterus (n01).
Results of further diagnostic workup
Eleven of the 86 patients had no further diagnostic workups.
Three of the 86 patients had diagnostic workups following
HSG without surgical procedures or further pathologies
identified.
Six of the 86 patients that solely had an miscarriage as the
outcome showed the following conditions:
& Two-sided tubal occlusion, normal LSC and HSC. Preg-
nancy after insemination (n01).
& One-sided tubal occlusion confirmed at LSC (n02), 1/2
with endometriosis at HSC.
& Two-sided tubal occlusion, fundus myoma at HSC not
visible at HSG (n01).
& Two-sided tubal occlusion, abortion after ovum dona-
tion (n01). This patient had no LSC because of her
relatively high age.
& Uterus arcuatus (ovarian insufficiency) (n01).
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Table 1 Summary of the distribution of pathologies and fertility outcomes, i.e., pregnancies and abortions following the 86 HSG examinations that
revealed pathological findings
Diagnosis at HSG: Results of further workup: Outcome:
Uterine pathologies (30):
Mucosal irregularities (4) Mucosal irregularities (4) 3/4 patients pregnant
Filling defects of the uterine cavity
(15)
Normal TVUS (4) 1/4 patients pregnant
Endometrial polyp (1) Pregnancy after resection
Uterus myomatosus (1) No pregnancy
Intramural and subserous myomas (1) No pregnancy
Invasive endometriosis and scarring (1) One miscarriage
Filling defects with unavailable follow-up information (5) Unknown
No workup, insemination therapy (2) No pregnancies
Müllerian duct anomalies:
Arcuate uterus (5) No workup (4), normal HSC and LSC apart from endometriosis (1) 1 normal pregnancy, 1
abortion
Hypoplastic uterus (4) 2 with normal ultrasound/HSC No pregnancies
Uterus septus (1) Confirmation at HSC, septum resected, no further follow-up information Unknown




History of salpingectomy (5) No pregnancies (4), unknown
(1)
Normal tubal morphology at laparoscopy (4) 2 patients with successful
pregnancies, 2 with
miscarriages
Hydatid cyst occluding tube at laparoscopy (1) No pregnancy
History of sterilization and refertilization (1) No pregnancy
One-sided tubal malformation (1) Spontaneous pregnancy
No further workup (2) No pregnancies
No follow-up information available (3) Unknown
Two-sided tubal occlusion (6) Normal tubal aspect at laparoscopy (3) 1 miscarriage after
insemination
Normal tubal aspect, endometriosis (1) No pregnancy
Two-sided sactosalpinx (1) No pregnancy
Tubes patent at laparoscopy, additional myoma identified and resected (1) 1 miscarriage after
spontaneous pregnancy
Tubal pathologies (continued)
Sactosalpinx (5) Unknown (1), therapeutic fimbriostomy (3), one of these tested positive
for chlamydia
No pregnancies
Spontaneous pregnancy before workup (1) 1 spontaneous pregnancy
Postinfectious tubal irregularities
(2)
No further workup 1 spontaneous pregnancy
Postoperative tubal pathology (1) No further workup No desire for children
Left tube occluded, right
salpingitis isthimica nodosa (1)
Left tube was resected, right normal aspect at LSC No desire for children
Right tube occluded, both tubes
with postinfectious abnormalities
(1)
LSC planned 2 spontaneous abortions years
ago
Filling defect in a proximal tube
(1)
Unknown
Salpingitis isthimica nodosa (1) Unknown
Aspect of peritubal adhesions (12) Additional polyp identified at HSC, normal tubes at LSC (1) 1 miscarriage (patient with
resected polyp)
No further consequence (10) 1 spontaneous pregnancy
Unknown (1) 2 pregnancies after ICSI
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One of the 86 patients had a miscarriage that was fol-
lowed by a successful pregnancy. In this patient, the HSG
showed a cavity abnormality due to adenomyosis/synechiae.
The HSC diagnosis showed multiple scars. An additional
myoma that was not visible at HSG was resected (Fig. 3).
Four of the 86 patients had resection of a myoma (n03)
or a polyp (n01) prior to becoming pregnant. Three of these
HSG examinations identified filling defects, and one was
not visible. One of these four patients had a spontaneous
abortion prior to a normal birth. The other three patients
gave birth to healthy children.
Forty-one of the 86 patients had no further treatment and
no pregnancies. Two of these patients had no wish for
further children; the examination was performed to assess
the need for anticonception.
For 20 of the 86 (23 %) patients, follow-up information
was unavailable. Approximately half of these patients were
referred from outside institutions for HSG examinations
Table 1 (continued)
Diagnosis at HSG: Results of further workup: Outcome:
Combined uterine and tubal pathologies (9)
Filling defects and one-sided
proximal tubal occlusion (3)
Tubes: Normal tube morphology at LSC but not patent (2), history of
salpingectomy (1). Uterus: Polyps (1), normal morphology (1),
unknown (1)
No pregnancies
Filling defect and sactosalpinx (1) No follow-up Unknown
Sactosalpinx and cervical
pathology (1)
Salpingitis follicularis, history of extrauterine gravidity No pregnancy
Filling defect and adhesions (1) Polyp removed at HSC No pregnancy











Normal TVUS 1 sponataneous abortion and 1
normal pregnancy following
Fig. 2 A 35-year-old patient: The irregular-shaped defect localised at
the right side of the cervix was identified as a myoma using trans-
vaginal sonography. No tubal pathology. No follow-up information
was available for this external patient
Fig. 3 A 36-year-old patient: Small and irregular bordered uterine
cavity with multiple linear constrictions. LSC and HSC were per-
formed, and the diagnoses of invasive endometriosis with multiple
scars and a single submucosal myoma were established. The submu-
cous myoma, which was not visible in HSG, was resected. Subse-
quently, the patient had two spontaneous pregnancies; the first resulted
in a spontaneous abortion, and the second was successful
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only, and the remainder were drop-outs from the fertility
program.
Discussion
In our fertility center, HSG is still the most common first-line
diagnostic test to evaluate the uterine cavity and tubal patency.
HSG is relatively easy to perform and can be completed as an
outpatient procedure. Using a good anesthetic protocol with
propofol sedation, the procedure is well tolerated by patients.
Whereas the administration of Propofol obviously increases
patient comfort, the procedure is performed without any se-
dation in many other institutions, and the advantages should
be discussed in light of the additional costs.
As recommended by the ESHRE guidelines [11], we
excluded other infertility causes, such as male or ovarian
factors, before performing a tubal patency test. According to
the ESHRE guidelines, a first-line laparoscopy/hystero-
scopy should be performed when tubal, uterine or pelvic
pathologies are suspected or detected by TVUS.
In recent years, CAT has become an important screening
test that can be used to decide upon further examinations
[10]. Hysterosalpingo contrast sonography (HyCoSy) has
become an important tool for the diagnosis of uterine or
tubal pathologies [12]. According to the literature, this tech-
nique has a higher sensitivity than HSG (0.80 versus 0.53)
[13], and the specificity (0.84 versus 0.87) is similar for both
exams [14].
In our opinion, HyCoSy is more demanding for the
examiner than HSG, it is better for assessing the uterine
cavity than the fallopian tubes , and it has a longer learning
curve. The advantages of hysterosalpingo contrast sonogra-
phy are that it costs less and causes less pain; therefore, no
Fig. 4 A 32-year-old patient: Symmetrically separated uterine cavity
(uterus septus). Also, notice venous intravasation of the contrast me-
dium (this can impede the image interpretation). LSC and HSC were
performed, and the septum was resected. After this procedure, the
patient was lost to follow-up
Fig. 5 A 31-year-old patient:
Suspected uterus unicornis uni-
collis at HSG (a) was identified
as bicornis bicollis with MRI
(b). MRI: T2-weighted, trans-
versal oblique MRI of the pel-
vis demonstrates two uterine
cavities separated by a muscular
layer. Laparascopy is planned
Fig. 6 A 37-year-old patient: Dilated fallopian tubes without contrast
spillage into the abdominal cavity (bilateral sactosalpinx). Following
HSG, an LSC was performed including left-sided salpingectomy and
right-sided adhesiolysis because of follicular salpingitis and peritubar
adhesions, respectively. The HSC was normal. The patient had no
recorded pregnancies to date
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anesthesia is necessary. Additionally, there is no exposure to
radiation.
Whereas HyCoSy and HSG only have diagnostic value,
laparoscopy and hysteroscopy also have therapeutic options,
including adhesiolysis, excision of endometriotic lesions or
resection of intrauterine polyps.
Considering that HSG is far more expensive and invasive
(i.e., anesthesia, exposure to radiation) than HyCoSy, our aim is
to avoid unnecessary HSG exams. Since 2009, we have rou-
tinely used CAT screening to select patients for laparoscopy/
hysteroscopy as the first-line exam, andwe have set an age limit
of 38 years, above which we perform HyCoSy instead of HSG.
During the years of our retrospective study from 2006 to
2010, we chose the diagnostic procedure according to the
criteria shown in Table 2. One of the aims of our retrospective
study was to improve our decision-making and to avoid
unnecessary exams. Of the 411 analysed HSGs, 86 (21 %)
demonstrated at least one pathology described as potentially
relevant for fertility. This is quite a low detection rate, mean-
ing that we performed four of five HSG procedures in vain.
This clearly indicates that the indication for HSG at our
institution in recent years was too broad. Furthermore, there
was a high false-positive rate for proximal tubal occlusion
(39 %) and a high pregnancy rate in patients with pathological
HSG, i.e., 25/86 of the total patients and 25/66 of the patients
with follow-up.
We acknowledge some limitations to our study. First, the
retrospective study design might appear to be a limitation of
this study; however, all of the images from the examinations
had been archived in our PACS, and all pathological cases
were re-evaluated. No follow-up information was available
for 23 % of the patients with a pathological condition at
HSG. It is not known how many of these patients became
pregnant. Dropout rates have been reported in the literature
to be as high as 50 % before the beginning of therapy. It is
likely that patients interrupt their fertility care because of
emotional distress and poor prognoses [15]. Furthermore,
some follow-ups were not available in our study for patients
sent to our center only for tubal assessments by their gynae-
cologists or family doctors.
Another limitation is that laparoscopic and/or hystero-
scopic results were available in only 29 of 411 HSG
patients. This means that there was no information about
possibly false-negative exams in the patients with normal
HSG exams. From the 86 HSG exams with suspected pa-
thologies, 29 patients had laparoscopy/hysteroscopy, and 20
patients were lost to follow-up. Therefore, it is not known
how many of these patients became pregnant.
In conclusion, HSG is a safe, low cost and, with the
application of propofol sedation, a well-tolerated procedure
for tubal assessment, which should be performed at the end
of the infertility investigation protocol. The relatively low
percentage (21 %) of pathological exams in our population
underlines the need for good patient preselection. The high
false-positive rate for proximal tubal occlusion (39 %),
Fig. 7 A 38-year-old patient. HSG: Irregular nodular configuration of
the right tube (salpingitis isthmica nodosa). The left tube is proximally
occluded. Because the patient had decided that she did not want more
children, there was no further workup. The HSG was performed to
assess the need for anticonception. History: Low anterior rectum re-
section. Reanastomosis of the right tube. Resection of the left tube.
Right tube normal at laparascopy 3 years before HSG
Table 2 Current diagnostic workup for evaluation of tubal and uterine factors in our fertility center
HyCoSy HSG Laparoscopy/hysteroscopy
Normal TVUS Normal TVUS Relevant pathological TVUS
CAT negative CAT negative CAT positive
Planned IVF/ICSI No history of PID, pelvic surgery or suspected
endometriosis
History of PID, pelvic surgery, suspected
endometriosis
Planned IUI ♀≥38 years Planned IUI ♀<38 years Relevant pathology in HyCoSy or HSG
Planned therapy of ovulatory disorder ♀≥
38 years
Planned therapy of ovulatory disorder ♀<38 years No primary indication for IVF/ICSI
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probably due to tubal spasm, demonstrates the importance of
antiperistaltic agents and delayed imaging. Furthermore, we
observed a high pregnancy rate (in patients with pathological
HSG). Most cases of pregnancy were spontaneous without
tubal or uterine surgery. This could mean that the indication
for HSG was too broad or that there could even be a thera-
peutic effect of the HSG procedure, i.e., improved patency of
the fallopian tube because of the flushing during the exami-
nation [16]. As a result of this data analysis and literature
review, the workflow in our own center will be adapted. We
will establish hysterosalpingo-contrast sonography (HyCoSy)
as a first-line exam for tubal and uterine factors, and improve
the patient selection for primary laparoscopy/hysteroscopy
using routine screening for CAT.
Take home points
– With antibiotic prophylaxis, no complications were ob-
served during or following any of the 411 examinations
performed at our institution during the study period.
– Low detection rate (21 % pathological exams).
– High false-positive rate for proximal tubal occlusion of
9/23 (39 %), demonstrating the importance of waiting
longer after the injection of buscopan to rule out tubal
spasm.
– High pregnancy rate in patients with pathological HSG:
25/86 of the total patients and 25/66 of the patients with
follow-up. Most pregnancies were spontaneous without
tubal or uterine surgery. This could mean that the indi-
cation for HSG was too broad or that there could even
be a therapeutic effect of the procedure, i.e., that the
flushing of the fallopian tubes could improve their
patency.
– As a result of this study and the review of the literature,
our own center aims to establish hysterosalpingo-contrast
sonography (HyCoSy) as a first-line exam to assess tubal
and uterine factors and to improve patient selection for
primary laparoscopy/hysteroscopy by introducing routine
screening for CAT.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution License which permits any use, distribution,
and reproduction in any medium, provided the original author(s) and
the source are credited.
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